Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Shanghai Pharma to Spend $80 Million on North China Expansion

publication date: Feb 9, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shanghai Pharmaceuticals announced a plan to set up a Beijing headquarters for North China. The company will establish a new entity, which will be called Shanghai Pharma Northern Investment Co., Ltd. and capitalized with $80 million. According to the company, Shanghai Pharma Northern will coordinate the company’s various subsidiaries in the region and take responsibility for further investment in North China. More details....

Stock Symbol: (SHA: 601607; HKEX: 02607)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...